- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 31.2M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5.7M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.59M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $18.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $16.6M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $18.55M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $17.12M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $46.38M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $44.46M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $48.6M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $47.17M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 31M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.21M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $28.09M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $27.72M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $389.89K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.21M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.77M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.7M |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.88M |